Want to join the conversation?
$MYL said it agreed to buy the non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings for $950MM in cash at closing, plus additional contingent payments of up to $50MM. The transaction, which will likely close by end of 3Q16, is expected to immediately add to $MYL's adjusted EPS upon closing.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.